跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brytim - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brytim
Approved
STANDARD
Brytim
Remington Pharmaceutical (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ad8667f18ef29cef
Company
Remington Pharmaceutical (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
ad8667f18ef29cef
Drug Approval Philippines Name
Brytim
Product Name
Brytim
Registration Number
DR-XY46247
Brand Name
Brytim
Generic Name
Brimonidine Tartrate + Timolol (as maleate)
Dosage Form
Sterile Ophthalmic Solution (Eye Drops
Dosage Strength
2 mg/5 mg per mL (0.2%/0.5 w/v)
Manufacturer
Remington Pharmaceutical (Pvt.) Ltd.
Importer
Reg-A Solutions Inc.
Distributor
Reg-A Solutions Inc.
Issuance Date
28 September 2024
Expiry Date
07 February 2030
Pharmacologic Category
Adrenergic Agonist (Alpha-2 Selective) / Beta-Adrenoceptor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ad8667f18ef29cef
Type
Standard
Back to Philippines FDA Approvals